1,272
Participants
Start Date
January 31, 2007
Primary Completion Date
April 30, 2008
Study Completion Date
May 31, 2008
Pyronaridine artesunate
Oral PA (180:60mg tablets) once a day plus AL-placebo (twice a day) for 3 consecutive days (Day 0, 1, and 2)
Coartem® (artemether lumefantrine)
AL (20:120mg tablets) twice a day plus PA-placebo (once a day) for 3 consecutive days (Day 0, 1, and 2)
RSUD TC Hillers, Maumere
Ecole de Santé Publique, Faculté de Médecine, Université de Kinshasa, Kinshasa
Komfo Anoykye Teaching Hospital, Kumasi
Jayapura General Hospital (RSUD) DOK II, Jayapura
Siaya District Hospital, Medical Superintendent's office, Siaya
Malaria Research and Training Center, Faculté de Médecine, de Pharmacie et d'Ondonto-stomatologie, Bamako
Instituto Nacional de Saude, Ministero de Saude, Maputo
Puerto Princesa General Hospital, Puerto Princesa City
Service de Parasitologie, Faculté de Médecine, Université Cheikh Anta Diop, Dakar
Farafenni Field Station, c/o: MRC Laboratories, Fajara
Shin Poong Pharmaceuticals
INDUSTRY
Medicines for Malaria Venture
OTHER